Liminatus Pharma Inc. has announced the unregistered issuance of 4,000,000 shares of its common stock to Clear Street LLC. The shares were issued in exchange for the surrender and cancellation of 805,377 warrants previously held by Clear Street LLC. This transaction was conducted without the payment of any commission or other remuneration and relied on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933. The agreement also includes the dismissal of pending litigation between the two parties.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-012016), on February 09, 2026, and is solely responsible for the information contained therein.